Research Analysts Offer Predictions for Viemed Healthcare, Inc.’s FY2023 Earnings (NASDAQ:VMD)

Viemed Healthcare, Inc. (NASDAQ:VMDGet Rating) – Analysts at Bloom Burton issued their FY2023 EPS estimates for Viemed Healthcare in a research note issued on Monday, March 6th. Bloom Burton analyst P. Pandurangan expects that the company will post earnings of $0.30 per share for the year. The consensus estimate for Viemed Healthcare’s current full-year earnings is $0.30 per share. Bloom Burton also issued estimates for Viemed Healthcare’s FY2024 earnings at $0.55 EPS.

Viemed Healthcare Price Performance

Shares of NASDAQ:VMD opened at $9.20 on Thursday. Viemed Healthcare has a 1-year low of $4.36 and a 1-year high of $9.41. The company has a market capitalization of $349.78 million, a P/E ratio of 61.33 and a beta of 1.47. The firm’s 50 day simple moving average is $8.40 and its two-hundred day simple moving average is $7.16.

Insider Buying and Selling at Viemed Healthcare

In other news, Director Timothy Smokoff sold 11,900 shares of the business’s stock in a transaction on Wednesday, December 21st. The shares were sold at an average price of $10.40, for a total value of $123,760.00. Following the transaction, the director now owns 67,332 shares of the company’s stock, valued at $700,252.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 17.20% of the company’s stock.

Institutional Investors Weigh In On Viemed Healthcare

Large investors have recently bought and sold shares of the business. Jane Street Group LLC bought a new position in Viemed Healthcare during the fourth quarter valued at $147,000. Lazard Asset Management LLC bought a new position in shares of Viemed Healthcare in the fourth quarter worth about $32,000. Man Group plc bought a new position in shares of Viemed Healthcare in the fourth quarter worth about $129,000. EAM Global Investors LLC grew its holdings in shares of Viemed Healthcare by 2.7% in the fourth quarter. EAM Global Investors LLC now owns 387,850 shares of the company’s stock worth $2,940,000 after purchasing an additional 10,245 shares during the last quarter. Finally, Forager Capital Management LLC bought a new position in shares of Viemed Healthcare in the fourth quarter worth about $10,828,000. Institutional investors own 46.04% of the company’s stock.

About Viemed Healthcare

(Get Rating)

Viemed Healthcare, Inc engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA.

Read More

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with's FREE daily email newsletter.